Advancing Phase 3 Lasofoxifene Development Program of Novel Selective Estrogen Receptor Modulator, a

YLÖJÄRVI, Finland--(BUSINESS WIRE)--Merus Power Oyj has signed a battery energy storage deal worth a

Federated Hermes Inc. lessened its position in Merus N.V. (NASDAQ: MRUS) by 18.3% during the undefin

Merus N.V. (NASDAQ: MRUS - Get Free Report) has earned an average recommendation of "Hold" from the

Stock News BYD overtakes Tesla in EV sales: Tesla (TSLA) delivered 1.64M vehicles in 2025, ceding th

Stock News U.S. futures rise on first trading day: Tech leaders Nvidia (NVDA), Palantir (PLTR), Appl

Stock News Street sets 2026 expectations: Wall Street sees the S&P 500 posting modest-to-mid-teens g

Merus N.V. (NASDAQ: MRUS - Get Free Report) major shareholder A/S Genmab bought 2,978 shares of Meru

Stock News Buffett hands CEO role to Abel: Berkshire Hathaway (BRK.B) founder Warren Buffett (Trades

Merus N.V. (NASDAQ: MRUS - Get Free Report) major shareholder A/S Genmab acquired 15,710 shares of t

Merus N.V. (NASDAQ: MRUS - Get Free Report) saw some unusual options trading on Friday. Traders acqu

Guru Stock PicksThird Avenue Value Fund has made the following transactions:Reduce in XTER: BMW by 5

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) (“Genmab”) announced today that the

Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy

Ensign Peak Advisors Inc increased its stake in Merus N.V. (NASDAQ: MRUS) by 72.4% during the undefi

Bicara Therapeutics (BCAX) is initiated with a Buy rating, driven by promising data for its HNSCC ca

SAN DIEGO and UTRECHT, The Netherlands and CAMBRIDGE, Mass. , Nov. 17, 2025 /PRNewswire/ -- Merus N.

https://ml-eu.globenewswire.com/Resource/Download/446c3266-6d5c-48ac-9a4e-4d559364ceb1

/PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Clas

The market continues to trade deeper in overbought territory based on most traditional valuation met

– 100% response rate in 1L left-sided mCRC (n=8, confirmed and unconfirmed) – 62% response rate in 2

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on M

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The comp

U.S. stocks were mixed, with the Nasdaq Composite gaining more than 100 points on Monday. Shares

Genmab A/S (NASDAQ: GMAB) on Monday agreed to acquire Merus N.V.

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday&#39

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announce

Genmab to acquire Merus for USD 97.00 per share in an all-cash transaction representing a transactio

11 mid-cap stocks soared last week, including LZ Technology, Centrus Energy, e.l.f Beauty, Merus, Ok

Top mid-cap stocks gained up to 53.47% in the last week, including QBTS, RGC, AAP, MRUS, OKLO, SBSW,

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday afte

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Frid

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares rose 60.2% to $1.7136. Avadel Pharmaceut

  On Wednesday, 215 companies set new 52-week lows.

Gainers

Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08

Gainers Newegg Commerce Inc. (NASDAQ: NEGG) shares jumped 30% to $12.03.

    This morning 163 companies set new 52-week highs.

  During Thursday's morning trading, 190 companies set new 52-week highs.